尽管公司的利超过预期, 但罗宾斯和鲁宾斯坦卖出了大量股票. Robins and Rubinstein sold significant stock, though company beat earnings estimates.

适应生物技术公司 (纳斯达克:ADPT) 最近有两位高管出售了大量股票. Adaptive Biotechnologies (NASDAQ: ADPT) saw two top executives sell significant stock holdings recently. 首席执行官查德·罗宾斯出售了约56万6千美元的股票, 而运营总监朱莉·鲁宾斯坦则卖掉近410万美元. CEO Chad Robins sold about $566,000 in shares, while COO Julie Rubinstein sold nearly $4.1 million. 这些销售是根据事先安排的交易计划进行的. The sales occurred under pre-arranged trading plans. 尽管有内部人士的销售,但公司报告财务业绩强,收入增长超过预期. Despite these insider sales, the company reported strong financial results, beating earnings estimates with rising revenue. 分析师对该股票的未来表现持分见. Analysts remain divided on the stock's future performance.